Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Pfizer Inc at TD Cowen Health Care Conference Transcript

Mar 04, 2024 / 04:10PM GMT
Release Date Price: €23.9 (-2.65%)
Stephen Michael Scala
TD Cowen, Research Division - MD & Senior Research Analyst

Well, good morning once again. We're delighted to have Pfizer here at Cowen's 44th Annual Healthcare Conference. Representing the company, Dave Denton, who is Chief Financial Officer as well as Executive Vice President, will start out. Dave is going to give a few thoughts about Pfizer and the outlook, and then we'll dive into our questions as well, as very importantly, your questions.

David M. Denton
Pfizer Inc. - CFO & Executive VP

Great. Thank you. And thank you again for hosting me, Steve, and my Investor Relations team, and thank you for your interest in Pfizer. Before I get started, my lawyers want me to make sure that I disclose that today we might make some forward-looking statements and discussion of many non-GAAP measures. You can see some explanation of that and some additional information in our SEC filings and on our Investor Relations website at Pfizer.

So with that, again, thank you again for your interest in Pfizer. I just want to make sure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot